Cystic Fibrosis Clinical Trial
Official title:
A Pilot Study to Assess the Use of MRI in the Assessment of Patients With Cystic Fibrosis and Primary Ciliary Dyskinesia
This is a small pilot / feasibility study (Approximately 50 patients) to assess the
possibility of clinical implementation of MRI assessment of patients with cystic fibrosis and
primary ciliary dyskinesia.
Patients will undergo their standard CT imaging and lung function investigations and
additionally will undergo MRI examination. Reports from CT (the current gold standard) and
MRI will be assessed for concordance and patient acceptability and examination implementation
costs will also be assessed. Novel MRI-based potential markers of CF and PCD disease state
will also be assessed.
In this small single site pilot / feasibility study we aim to recruit approximately 50
patients over the age of 6 years with known cystic fibrosis (CF) or primary ciliary
dyskinesia (PCD).
Patients will be recruited from routine clinic appointments or at admission for inpatient
investigation and/or treatment at the point of referral for computed tomography (CT)
examination. If they consent to participation they will undergo MRI examination in addition
to their standard clinical CT (within 7 days of the CT scan - on the same day if
practicable).
The magnetic resonance imaging (MRI) scans will be anonymised and reported by radiologists,
blinded to the CT findings. The reports and scores (Eichinger and Brody2) will then be
compared those of the standard CT to assess concordance between the modalities and inter and
intra observer variability.
Potential novel biomarkers (pulmonary ventilation and perfusion (non-contrast) and sinus
mucus and liver tissue characteristics) will be compared with established markers (including
lung clearance index) and known CF mutation / PCD type.
Patients or their carers will also be asked to fill in a short questionnaire comparing the
differential patient acceptability of CT and MRI examinations. The cost (time, resources etc)
of each examination will be calculated and compared.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04696198 -
Thoracic Mobility in Cystic Fibrosis Care
|
N/A | |
| Completed |
NCT00803205 -
Study of Ataluren (PTC124™) in Cystic Fibrosis
|
Phase 3 | |
| Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
| Completed |
NCT03601637 -
Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Participants 1 to Less Than 2 Years of Age With Cystic Fibrosis, Homozygous for F508del
|
Phase 3 | |
| Terminated |
NCT02769637 -
Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)
|
||
| Recruiting |
NCT06032273 -
Lung Transplant READY CF 2: CARING CF Ancillary RCT
|
N/A | |
| Recruiting |
NCT06030206 -
Lung Transplant READY CF 2: A Multi-site RCT
|
N/A | |
| Recruiting |
NCT06012084 -
The Development and Evaluation of iCF-PWR for Healthy Siblings of Individuals With Cystic Fibrosis
|
N/A | |
| Recruiting |
NCT05392855 -
Symptom Based Performance of Airway Clearance After Starting Highly Effective Modulators for Cystic Fibrosis (SPACE-CF)
|
N/A | |
| Recruiting |
NCT06088485 -
The Effect of Bone Mineral Density in Patients With Adult Cystic Fibrosis
|
||
| Recruiting |
NCT04056702 -
Impact of Triple Combination CFTR Therapy on Sinus Disease.
|
||
| Recruiting |
NCT04039087 -
Sildenafil Exercise: Role of PDE5 Inhibition
|
Phase 2/Phase 3 | |
| Completed |
NCT04038710 -
Clinical Outcomes of Triple Combination Therapy in Severe Cystic Fibrosis Disease.
|
||
| Completed |
NCT04058548 -
Clinical Utility of the 1-minute Sit to Stand Test as a Measure of Submaximal Exercise Tolerance in Patients With Cystic Fibrosis During Acute Pulmonary Exacerbation
|
N/A | |
| Completed |
NCT03637504 -
Feasibility of a Mobile Medication Plan Application in CF Patient Care
|
N/A | |
| Recruiting |
NCT03506061 -
Trikafta in Cystic Fibrosis Patients
|
Phase 2 | |
| Completed |
NCT03566550 -
Gut Imaging for Function & Transit in Cystic Fibrosis Study 1
|
||
| Recruiting |
NCT04828382 -
Prospective Study of Pregnancy in Women With Cystic Fibrosis
|
||
| Completed |
NCT04568980 -
Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
|
||
| Recruiting |
NCT04010253 -
Impact of Bronchial Drainage Technique by the Medical Device Simeox® on Respiratory Function and Symptoms in Adult Patients With Cystic Fibrosis
|
N/A |